Bleeding defines cycle day one
The first day of menstrual bleeding begins the follicular phase. Low early-cycle estradiol and progesterone reduce feedback restraint on GnRH, LH, and FSH.
LIFE STAGES / 02
The ovarian follicular and luteal phases interact with uterine proliferative, secretory, and menstrual phases through hypothalamic, pituitary, ovarian, cervical, and endometrial feedback. A 28-day diagram is an orientation—not a universal clock.
The first day of menstrual bleeding begins the follicular phase. Low early-cycle estradiol and progesterone reduce feedback restraint on GnRH, LH, and FSH.
Several follicles may grow, but one commonly becomes dominant as estradiol and inhibin feedback lower FSH and the selected follicle remains responsive.
Follicular estradiol supports endometrial proliferation and makes cervical mucus more permissive around the fertile window.
Variation in cycle length often reflects variation before ovulation. Ovulation therefore does not reliably occur on cycle day 14.
Sustained high estradiol increases pituitary and hypothalamic drive, producing an LH surge rather than its more usual negative feedback.
Follicular enzymes, pressure, and tissue remodeling culminate in oocyte release; the remaining follicle then luteinizes.
The corpus luteum makes progesterone and estradiol, supporting glandular secretion, spiral-artery development, thicker cervical mucus, and a small temperature shift.
Early hCG preserves the corpus luteum after implantation. Without pregnancy, steroid support falls and endometrial shedding starts a new cycle.
Calendar apps, urinary LH, cervical mucus, and basal temperature observe different proxies; none alone guarantees ovulation, conception, or contraception.
Years after menarche, lactation, perimenopause, energy availability, stress, illness, and hormonal medicines can change frequency and bleeding.
Pregnancy, lactation, and menopause can stop periods; endocrine, energy, structural, genetic, medication, or other conditions can also do so.
Very heavy flow, severe or escalating pain, fainting, anemia symptoms, bleeding after menopause, or bleeding with possible pregnancy should not be normalized by a cycle chart.